[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)

NCT02621606 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: [11C]MK-6884

Sponsor

Merck Sharp & Dohme LLC